Variant report
Variant | esv994842 |
---|---|
Chromosome Location | chr19:42813904-42814432 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:61)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:42814045-42814095 | NT2-D1 | testis: | n/a |
2 | chr19:42814045-42814095 | PrEC | prostate: | n/a |
3 | chr19:42814045-42814095 | HCT-116 | colon: | n/a |
4 | chr19:42814045-42814095 | AoSMC | blood vessel: | n/a |
5 | chr19:42814045-42814095 | HRCEpiC | kidney: | n/a |
6 | chr19:42814045-42814095 | CMK | blood: | n/a |
7 | chr19:42814045-42814095 | HRPEpiC | eye: | n/a |
8 | chr19:42814045-42814095 | AG04449 | skin: | fetal |
9 | chr19:42814045-42814095 | HMEC | breast: | n/a |
10 | chr19:42814045-42814095 | RPTEC | kidney: | n/a |
11 | chr19:42814045-42814095 | IMR90 | lung: | fetal |
12 | chr19:42814045-42814095 | SK-N-SH_RA | brain: | n/a |
13 | chr19:42814045-42814095 | HCF | heart: | n/a |
14 | chr19:42814045-42814095 | Caco-2 | colon: | n/a |
15 | chr19:42814045-42814095 | HepG2 | liver: | n/a |
16 | chr19:42814045-42814095 | LNCaP | prostate: | n/a |
17 | chr19:42814045-42814095 | GM12892 | blood: | n/a |
18 | chr19:42814045-42814095 | HUVEC | blood vessel: | n/a |
19 | chr19:42814045-42814095 | SK-N-SH | brain: | n/a |
20 | chr19:42814045-42814095 | AG10803 | skin: | n/a |
21 | chr19:42814045-42814095 | SAEC | small airway: | n/a |
22 | chr19:42814045-42814095 | Jurkat | blood: | n/a |
23 | chr19:42814045-42814095 | GM12891 | blood: | n/a |
24 | chr19:42814045-42814095 | Hepatocyte | liver: | n/a |
25 | chr19:42814045-42814095 | NH-A | brain: | n/a |
26 | chr19:42814045-42814095 | PFSK-1 | brain: | n/a |
27 | chr19:42814045-42814095 | ProgFib | skin: | n/a |
28 | chr19:42814045-42814095 | NHBE | bronchial: | n/a |
29 | chr19:42814045-42814095 | A549 | lung: | n/a |
30 | chr19:42814045-42814095 | HAEpiC | amniotic membrane: | n/a |
31 | chr19:42814045-42814095 | PANC-1 | pancreas: | n/a |
32 | chr19:42814045-42814095 | GM12878 | blood: | n/a |
33 | chr19:42814045-42814095 | H1-hESC | embryonic stem cell: | embryo |
34 | chr19:42814045-42814095 | HEK293 | kidney: | embryo |
35 | chr19:42814045-42814095 | HCM | heart: | n/a |
36 | chr19:42814045-42814095 | HNPCEpiC | eye: | n/a |
37 | chr19:42814045-42814095 | HCPEpiC | choroid plexus: | n/a |
38 | chr19:42814045-42814095 | AG09309 | skin: | n/a |
39 | chr19:42814045-42814095 | ECC-1 | luminal epithelium: | n/a |
40 | chr19:42814045-42814095 | SK-N-MC | brain: | n/a |
41 | chr19:42814045-42814095 | Hela-S3 | cervix: | n/a |
42 | chr19:42814045-42814095 | GM19239 | blood: | n/a |
43 | chr19:42814045-42814095 | HRE | kidney: | n/a |
44 | chr19:42814045-42814095 | NHDF-neo | bronchial: | n/a |
45 | chr19:42814045-42814095 | HEEpiC | esophagus: | n/a |
46 | chr19:42814045-42814095 | BE2_C | brain: | n/a |
47 | chr19:42814045-42814095 | HL-60 | blood: | n/a |
48 | chr19:42814045-42814095 | BJ | skin: | n/a |
49 | chr19:42814045-42814095 | T-47D | breast: | n/a |
50 | chr19:42814045-42814095 | SKMC | muscle: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:42775700..42778314-chr19:42814238..42816528,2 | K562 | blood: | |
2 | chr19:42804082..42810862-chr19:42813351..42818872,10 | K562 | blood: | |
3 | chr19:42800037..42802686-chr19:42813710..42815319,2 | MCF-7 | breast: | |
4 | chr19:42804981..42810862-chr19:42813585..42819261,9 | K562 | blood: | |
5 | chr19:42814347..42817419-chr19:42838492..42840570,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TMEM145 | CpG island |
ENSG00000188368 | chromatin interactions |
ENSG00000079462 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147433253 | chr19:42813920-42813921 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs532229363 | chr19:42813921-42813922 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs139403468 | chr19:42813938-42813939 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs377275637 | chr19:42813939-42813940 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs369857462 | chr19:42813948-42813949 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs145027553 | chr19:42813949-42813950 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs141255938 | chr19:42813956-42813957 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs201566662 | chr19:42813971-42813972 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs529623831 | chr19:42813974-42813975 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs200535855 | chr19:42813988-42813989 | Weak transcription Genic enhancers Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs567580310 | chr19:42814031-42814032 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs78424339 | chr19:42814045-42814046 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs199870306 | chr19:42814072-42814073 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs139508954 | chr19:42814091-42814092 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs149700943 | chr19:42814129-42814130 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs571436612 | chr19:42814132-42814133 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs5024181 | chr19:42814144-42814145 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs200698601 | chr19:42814146-42814147 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs553943850 | chr19:42814159-42814160 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs143542522 | chr19:42814166-42814167 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs5024182 | chr19:42814172-42814173 | Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs145319764 | chr19:42814209-42814210 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs199970161 | chr19:42814214-42814215 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs554910146 | chr19:42814224-42814225 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs369573882 | chr19:42814225-42814226 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs200334665 | chr19:42814231-42814232 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs376915635 | chr19:42814251-42814252 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs5024183 | chr19:42814258-42814259 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs201988349 | chr19:42814264-42814265 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs374300391 | chr19:42814299-42814300 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs78579884 | chr19:42814302-42814303 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs143861655 | chr19:42814303-42814304 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs368156714 | chr19:42814313-42814314 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs201124925 | chr19:42814343-42814344 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs370952874 | chr19:42814356-42814357 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs145650509 | chr19:42814369-42814370 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs200342465 | chr19:42814379-42814380 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs559155617 | chr19:42814391-42814392 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs376284106 | chr19:42814416-42814417 | Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs184419176 | chr19:42814423-42814424 | Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs267605513 | chr19:42814427-42814428 | Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs117105573 | chr19:42814428-42814429 | Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Genital abnormality | 22378287 | CNVD |
Hypospadia | 22378287 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:42807200-42817200 | Weak transcription | Right Atrium | heart |
2 | chr19:42807600-42814600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr19:42807800-42814200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr19:42807800-42815800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr19:42807800-42815800 | Weak transcription | Fetal Stomach | stomach |
6 | chr19:42807800-42816200 | Weak transcription | Brain Germinal Matrix | brain |
7 | chr19:42808000-42815600 | Weak transcription | Fetal Brain Female | brain |
8 | chr19:42808200-42817000 | Weak transcription | K562 | blood |
9 | chr19:42808400-42816600 | Weak transcription | Gastric | stomach |
10 | chr19:42811200-42814200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr19:42811400-42816600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr19:42811400-42817200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr19:42813600-42814000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr19:42813600-42814000 | Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr19:42814000-42814200 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr19:42814000-42814600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
17 | chr19:42814000-42814800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr19:42814200-42814400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr19:42814200-42814800 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
20 | chr19:42814400-42814600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |